Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Riley

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Lancet (London, England)|July 29, 1978
Increased dopamine-receptor sensitivity in schizophreniaF Owen, A J Cross, T J Crow, et al.
The Journal of Physiology|July 1, 1978
Evidence for increased dopamine receptor sensitivity in post mortem brains from patients with schizophrenia [proceedings]A J Cross, T J Crow, A Longden, et al.
Lancet (London, England)|June 11, 1977
New direction to the amine hypothesisD M Shaw, G J Riley, A C Michalakeas, et al.
Infection and Immunity|January 1, 1997
Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adultsM A Shelly, H Jacoby, G J Riley, et al.
Psychopharmacology|October 31, 1978
The activities of brain dopamine-beta-hydroxylase and catechol-O-methyl transferase in schizophrenics and controlsA J Cross, T J Crow, W S Killpack, et al.
Journal of Neural Transmission. Supplementum|January 1, 1979
Distribution of tryptophan and tyrosine in unipolar affective disorders as defined by multicompartmental analysisD M Shaw, R Blazek, S F Tidmarsh, et al.
Lancet (London, England)|November 19, 1977
Platelet monamine oxidase in schizophreniaF Owen, A J Cross, T J Crow, et al.
European Journal of Pharmacology|October 26, 2000
Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptorM D Wood, I Boyfield, D J Nash, et al.
Clinical Orthopaedics and Related Research|November 1, 1982
Meningococcal arthritis, bacteremia, and osteomyelitis following arthroscopy. Report of a caseG W Christopher, J A Jurik, C J Janecki, et al.
Journal of Medicinal Chemistry|June 26, 1992
Substituent variation in azabicyclic triazole- and tetrazole-based muscarinic receptor ligandsS M Jenkins, H J Wadsworth, S Bromidge, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|July 29, 1978
Increased dopamine-receptor sensitivity in schizophreniaF Owen, A J Cross, T J Crow, et al.
The Journal of Physiology|July 1, 1978
Evidence for increased dopamine receptor sensitivity in post mortem brains from patients with schizophrenia [proceedings]A J Cross, T J Crow, A Longden, et al.
Lancet (London, England)|June 11, 1977
New direction to the amine hypothesisD M Shaw, G J Riley, A C Michalakeas, et al.
Infection and Immunity|January 1, 1997
Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adultsM A Shelly, H Jacoby, G J Riley, et al.
Psychopharmacology|October 31, 1978
The activities of brain dopamine-beta-hydroxylase and catechol-O-methyl transferase in schizophrenics and controlsA J Cross, T J Crow, W S Killpack, et al.
Journal of Neural Transmission. Supplementum|January 1, 1979
Distribution of tryptophan and tyrosine in unipolar affective disorders as defined by multicompartmental analysisD M Shaw, R Blazek, S F Tidmarsh, et al.
Lancet (London, England)|November 19, 1977
Platelet monamine oxidase in schizophreniaF Owen, A J Cross, T J Crow, et al.
European Journal of Pharmacology|October 26, 2000
Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptorM D Wood, I Boyfield, D J Nash, et al.
Clinical Orthopaedics and Related Research|November 1, 1982
Meningococcal arthritis, bacteremia, and osteomyelitis following arthroscopy. Report of a caseG W Christopher, J A Jurik, C J Janecki, et al.
Journal of Medicinal Chemistry|June 26, 1992
Substituent variation in azabicyclic triazole- and tetrazole-based muscarinic receptor ligandsS M Jenkins, H J Wadsworth, S Bromidge, et al.
Pageof 5